American Cancer Society: Cancer Facts & Figures for African Americans 2007–2008. 2007, Atlanta, American Cancer Society
Google Scholar
Thomas H: The Slave Trade. The story of the Atlantic slave trade: 1440 – 1870. 1997, Simon and Schuster
Google Scholar
Lovejoy PE: Transformations in Slavery. 2000, Cambridge University Press
Google Scholar
Curtin P: Atlantic Slave Trade: A Census. 1990, University of Wisconsin Press
Google Scholar
Boddy-evans A: How many slaves were taken from Africa?. [http://africanhistory.about.com/cs/slavery/a/slavenumbers.htm]
Bandele K: Slave Trade Map & African-American Ancestry. [http://www.homestead.com/wysinger/mapofafricadiaspora.html]
Breaking the Silence, Learning about the Transatlantic Slave Trade by UNESCO, Anti-Slavery International, the British Council and the Norwegian Agency for Development Co-operation (NORAD). [http://www.antislavery.org/breakingthesilence/about.shtml]
Odedina FT, Ogunbiyi F, Ukoli F: Prostate cancer burden in African-Americans: Can the origin be traced to Ancestral African relatives?. J Natl Med Assoc. 2006, 98 (4): 539-543.
PubMed Central
PubMed
Google Scholar
Silverberg E, Lubera JA: Cancer statistics. CA Cancer J Clin. 1989, 39: 3-20. 10.3322/canjclin.39.1.3.
Article
CAS
PubMed
Google Scholar
Glover FE, Coffey DS, Douglas LL, Cadogan M, Russell H: The epidemiology of prostate cancer in Jamaica. J Urol. 1998, 159 (6): 1984-1986. 10.1016/S0022-5347(01)63220-8. discussion 1986–1987.
Article
PubMed
Google Scholar
Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. 2004, IARC Press, Lyon
Google Scholar
Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M: Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology. 2003, 61 (5): 987-92. 10.1016/S0090-4295(02)02588-8.
Article
CAS
PubMed
Google Scholar
Klufio GO: A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana. West Afr J Med. 2004, 23 (2): 131-134.
CAS
PubMed
Google Scholar
Wiredu EK, Armah HB: Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health. 2006, 6: 159-10.1186/1471-2458-6-159.
Article
PubMed Central
PubMed
Google Scholar
Bouchardy C, Mirra AP, Khlat M, Parkin DM, de Souza JM, Gotlieb SL: Ethnicity and cancer risk in São Paulo, Brazil. Cancer Epidemiol Biomarkers Prev. 1991, 1 (1): 21-27.
CAS
PubMed
Google Scholar
Barros MS, Silva VR, Santos GB, Hughes A, Silveira MA: Prevalence of prostate adenocarcinoma according to race in an university hospital. Int Braz J Urol. 2003, 29 (4): 306-311. 10.1590/S1677-55382003000400004.
Article
PubMed
Google Scholar
Paschoalin EL, Martins AC, Pastorello M, Sândis KA, Maciel LM: Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers. Int Braz J Urol. 2003, 29 (4): 300-305. 10.1590/S1677-55382003000400003.
Article
PubMed
Google Scholar
Brooks SE, Hanchard B, Wolff C, Samuels E, Allen J: Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 1988–1992. West Indian Med J. 1995, 44 (3): 102-105.
CAS
PubMed
Google Scholar
Hanchard B, Blake G, Wolff C, Samuels E, Waugh N: Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1993–1997. West Indian Med J. 2001, 50 (2): 123-129.
CAS
PubMed
Google Scholar
Blake G, Hanchard B, Mitchell K, Simpson D, Waugh N: Jamaica cancer mortality statistics, 1999. West Indian Med J. 2002, 51 (2): 64-67.
CAS
PubMed
Google Scholar
Bunker C, Patrick A, Miljkovic G, Konety BR, Belle A: Prostate Cancer Screening Parameters in a High-Risk African – Caribbean Population. Urology. 2004, 63 (4): 737-741. 10.1016/j.urology.2003.10.064.
Article
PubMed
Google Scholar
Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM: High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev. 2002, 11 (8): 726-729.
PubMed
Google Scholar
Bunker CH, Patrick AL, Maharaj G, Keenan HA, Ramnarine S: Prostate cancer risk is three-fold higher among men, aged 50–64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago. Ethn Dis. 2002, 12 (4): S3-30-33-
Google Scholar
Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T, Ben-Shlomo Y: Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London. BJU International. 2006, 98: 1216-1220. 10.1111/j.1464-410X.2006.06503.x.
Article
PubMed
Google Scholar
Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F: The Risk of Prostate Cancer amongst Black Men in the United Kingdom: the Process Cohort Study. Eur Urol. 2008, 53: 99-105. 10.1016/j.eururo.2007.02.047.
Article
PubMed
Google Scholar
Ukoli F, Osime U, Akereyeni F: Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Intern J Uro. 2003, 10 (6): 315-322. 10.1046/j.1442-2042.2003.00633.x.
Article
Google Scholar
Ogunbiyi JO, Shittu OB: Increased Incidence of Prostate Cancer in Nigerians. J Natl Med Assoc. 1999, 91: 159-164.
PubMed Central
CAS
PubMed
Google Scholar
Udeh IN: Prostate carcinoma in Nigeria: a 10 yr retrospective study. Int Urol Nephrol. 1981, 13: 159-166. 10.1007/BF02082060.
Article
CAS
PubMed
Google Scholar
Lawani J, Nkposong EO, Aghadiuno PU, Akute O: Twenty years review of genitourinary tract tumors in Ibadan. Cancer in Nigeria. Edited by: Solanke TF. 1982, Ibadan. Ibadan University Press, 67-
Google Scholar
Magoha GA: Epidemiological and Clinical aspects of Incidental Carcinoma of the Prostate in Africans. Experience at the Lagos University Teaching Hospital, Lagos and the Kenyatta National Hospital. Nairobi, East Afri Med J. 1995, 72 (5): 283-287.
CAS
Google Scholar
Akang EE, Aligbe JU, Olisa EG: Prostatic tumors in Benin city, Nigeria. West Afri J Med. 1996, 15: 56-60.
CAS
Google Scholar
Osegbe DN: Prostate cancer in Nigerians: facts and nonfacts. J Urol. 1997, 157 (4): 1340-1343. 10.1016/S0022-5347(01)64966-8.
Article
CAS
PubMed
Google Scholar
Eke N, Sapira MK: Prostate cancer in Port Harcourt, Nigeria: features and Outcome. Nig J Surg Res. 2002, 4 (1–2): 34-44.
Google Scholar
Nwofor AME, Oranusi CK: Cancer of the prostate: experience at Nnewi, Southeast, Nigeria. Nig J Clin Pract. 2004, 7 (2): 65-68.
Google Scholar
Dawan D, Rafindadi AH, Kalayi GD: Benign prostate hyperplasia and prostate carcinoma in native Africans. BJU Int. 2000, 85: 1074-1077. 10.1046/j.1464-410x.2000.00677.x.
Article
Google Scholar
Mohammed AZ, Alhassan SU, Edino ST, Ochicha O: Histopathological review of prostatic diseases in Kano, Nigeria. Niger Postgrad Med J. 2003, 10 (1): 1-5.
CAS
PubMed
Google Scholar
Ekwere PD, Egbe SN: The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. J Natl Med Assoc. 2002, 94 (7): 619-627.
PubMed Central
PubMed
Google Scholar
Mohammed AZ, Nwana EJC, Anjorin AS: Histological pattern of prostatic diseases in Nigerians. Afric J Uro. 2005, 11 (1): 33-38.
Google Scholar
Ogunbiyi JO: Epidemiology of cancer in Ibadan: tumors in adults. Arch Ibadan Med. 2000, 1 (2): 9-12.
Google Scholar
Jackson MA, Kovi J, Heshmat MY, Ogunmuyiwa TA, Jones GW: Characterization of prostatic carcinoma among Blacks: A comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate. 1980, 1 (2): 185-205. 10.1002/pros.2990010205.
Article
CAS
PubMed
Google Scholar
Angwafo FF: Migration and Prostate Cancer: An International Perspective. J Natl Med Assoc. 1998, 90 (11 Suppl): S720-S723.
PubMed Central
CAS
PubMed
Google Scholar
Waterhouse J, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan SL, (eds): Cancer Incidence in Five Continents. 1982, IARC SCi. Publications, Lyon, 42:4: 210-213.
Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powel J, (eds): Cancer Incidence in Five Continents. 1992, IARC Sci. Publications, Lyon, 120:vii: 45-55. 182–193.
Thomas JO: Cancer Registration and Diagnosis in Ibadan. Arch. Ibadan Med. 2000, 1: 5-6.
Google Scholar
Gronberg H: Prostate Cancer Epidemiology. Lancet. 2003, 361: 859-864. 10.1016/S0140-6736(03)12713-4.
Article
PubMed
Google Scholar